ZyVersa Therapeutics Inc. - Kapitalisasi Buku ZVSA

The current ZyVersa Therapeutics (ZVSA) share price chart reflects the dynamics of a business whose value is based on patents in the non-cyclical field of nephrology, with the current indicator standing at 0.02. Management is operating under resource constraints, adapting early treatment programs to meet venture capital expectations. Growth is accelerating through partnerships with medical funds, creating synergy in the blocking of inflammasomes.

ZVSA Kapitalisasi Buku ZyVersa Therapeutics, Inc. (28.04.2023 - 02.08.2025)

Rincian metrik lan analitis perusahaan ZyVersa (ZVSA)

- rega lan prakiraan konsensus rega:

Bagan bursa ZyVersa Therapeutics|ZVSA - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar ZyVersa Therapeutics Inc.|ZVSA - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham ZyVersa Therapeutics|ZVSA - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku zyversa.com|ZVSA - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal ZyVersa Therapeutics|ZVSA - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ZyVersa Therapeutics|ZVSA - Utang perusahaan|Utang marang nilai buku ZyVersa Therapeutics Inc.|ZVSA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ZyVersa Therapeutics

Pambiji fundamental:ZVSA - ZyVersa Therapeutics, Inc.

Book value reflects the net value of assets minus all liabilities, allowing an investor to assess the real internal capital of the business excluding market speculation. Analyzing the book capital chart reveals how the ZyVersa Therapeutics (ZVSA) strategy of outsourcing production and trials minimizes capital expenditures, maintaining the scientific team's financial flexibility and protecting the equity structure.

Analisis pesaing ZyVersa Therapeutics

TVTX - Pambiji Buku Bisnis|ARDX: Kapitalisasi Buku|PROK (prokidney.com) - Kapitalisasi Buku|Nilai Buku Perusahaan Akebia Therapeutics, Inc. AKBA|Nilai Aset Bersih Cara Therapeutics, Inc.|DiaMedica Pharma (DMAC) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Unicycive Therapeutics, Inc (UNCY)|Kapitalisasi Buku RMTI (Rockwell Medical, Inc.)|cadrenal.com - Kapitalisasi Buku|Nilai Buku Perusahaan Conduit Pharmaceuticals Inc. (CDT)|CALT: Nilai Akuntansi Perusahaan|RNLX (Renalytix) - Nilai Buku Perusahaan